PHA‐543613, an alpha‐7 nicotinic partial agonist, has been reported to improve MWM performance in Aβ25–35‐induced cognitive deficits mice (Sadigh‐Eteghad et al., 2015). This evidence concerns the gene PSMA3 and Cognitive impairment.